0001854270-24-000041.txt : 20240502 0001854270-24-000041.hdr.sgml : 20240502 20240502162444 ACCESSION NUMBER: 0001854270-24-000041 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240426 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Senti Biosciences, Inc. CENTRAL INDEX KEY: 0001854270 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 862437900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40440 FILM NUMBER: 24908759 BUSINESS ADDRESS: STREET 1: 2 CORPORATE DRIVE, FIRST FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 382-3281 MAIL ADDRESS: STREET 1: 2 CORPORATE DRIVE, FIRST FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Senti Biosciences, Inc.\ DATE OF NAME CHANGE: 20220615 FORMER COMPANY: FORMER CONFORMED NAME: Dynamics Special Purpose Corp. DATE OF NAME CHANGE: 20210331 8-K 1 snti-20240426.htm 8-K snti-20240426
0001854270FALSENasdaq00018542702024-04-262024-04-26











UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 2, 2024 (April 26, 2024)
___________________________________
SENTI BIOSCIENCES, INC.
(Exact name of Registrant as specified in its charter)
___________________________________
Delaware001-4044086-2437900
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
2 Corporate Drive, First Floor
South San Francisco, California 94080
(Address of principal executive offices including zip code)
Registrant’s telephone number, including area code: (650) 239-2030

(Former name or former address, if changed since last report)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol
Name of each exchange
on which registered
Common Stock, par value $0.0001 per shareSNTI
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Following approval by the Board of Directors (the “Board”) of Senti Biosciences, Inc. (the “Company”) on April 26, 2024, Timothy Lu, M.D., Ph.D., the Chief Executive Officer and President of the Company, was appointed to serve as the interim principal financial officer and principal accounting officer of the Company, effective as of May 4, 2024, until his successor as principal financial officer and principal accounting officer is duly appointed by the Board, or until his earlier death, resignation, retirement, removal or termination of his office as principal financial officer and principal accounting officer.

On May 1, 2024, following approval by the Board, Yvonne Li was appointed as Interim Chief Financial Officer and will assume the duties of the Chief Financial Officer, effective May 4, 2024. The Board also appointed Ms. Li to serve as the Company’s principal financial officer and principal accounting officer of the Company, effective immediately after the filing of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024. In connection with Ms. Li’s appointment, the Company has entered into a consulting agreement with Ms. Li (the “Li Consulting Agreement”), under which Ms. Li will provide services as chief financial officer of the Company and will receive a consulting fee of $350 per hour in cash for services provided to the Company with a maximum aggregate payment of $370,000.

The foregoing description of the Li Consulting Agreement does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety by reference to the full text of the Li Consulting Agreement, which the Company expects to file as an exhibit to its Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2024.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SENTI BIOSCIENCES, INC.
Date:
May 2, 2024
By:/s/ Timothy Lu, M.D., Ph.D.
Name:Timothy Lu, M.D., Ph.D.
Title:Chief Executive Officer and President


EX-101.SCH 2 snti-20240426.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 snti-20240426_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 snti-20240426_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
Apr. 26, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 26, 2024
Entity Registrant Name SENTI BIOSCIENCES, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40440
Entity Tax Identification Number 86-2437900
Entity Address, Address Line One 2 Corporate Drive, First Floor
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code 650
Local Phone Number 239-2030
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol SNTI
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period true
Entity Central Index Key 0001854270
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.sentibio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName - snti-20240426.htm 4 snti-20240426.htm snti-20240426.xsd snti-20240426_lab.xml snti-20240426_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "snti-20240426.htm": { "nsprefix": "snti", "nsuri": "http://www.sentibio.com/20240426", "dts": { "inline": { "local": [ "snti-20240426.htm" ] }, "schema": { "local": [ "snti-20240426.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "snti-20240426_lab.xml" ] }, "presentationLink": { "local": [ "snti-20240426_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://www.sentibio.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "snti-20240426.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "snti-20240426.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.sentibio.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001854270-24-000041-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001854270-24-000041-xbrl.zip M4$L#!!0 ( !6#HEB7RR8(ZP\ )5J 1 MWXCBR_SY_A2XS=SI]#@;;F&<2]J0)F>5.=Y(-S)G9_;)'V'+0MK$] MDIS _O6W2K9Y!$@@G0>9='\)MIY5^E6IJE16'_UM,@[(#1.21^'Q!ZMD?B L M="./A]?''T[ZG5[OP]_:/QS]CV'\\>GJ,SF-W&3,0D4Z@E'%/'++U8BH$2._ M1^(KOZ'D,J#*C\38,-)FG2B>"GX]4L0V;2>OEI>*UM#UZHYO4Z/AU6W#&38; MQK!2J1MFLUZCS;I3]:K5XG6KP1S?:E1=HU)WJ>$T/J-<]O.GKY0MOA$&9*YQX61 M4G&K7+Z]O2W!<^DZNBGS,. A0[++2M!0(E54 9_*MFE5#;-A5*Q"UL]D* *^ MU N^*47B&BJ;%>A+*AJZ;%9?+M>^K>1UK?(?7S[WW1$;4^-N*S[9-(1569AN M7MUC\T%TW9PR*( V=F7>KUK?\7TLL$W#M W+GI$$5;^N(\IJ-IME79I5W5P) M5R;O;Z6[98YB\9#*E#>M@ )>"RPT?NL7VDN'973ET?EM.MA MY$W;1QZ_(5)- W9<\+B, SIMA5'(8 )\TL**3*0_N>>Q4/^$\G,0(,'==/R) MNF+^<<$U $DA'6-/C+>Z,+::=F!V@@:]T&.37]FT0+AW7/ -VRZT3[-1*X7VV=,$#TGME8%=7J_+B_VW<;M_-5R[S&P M)_+R)U B0IV"NFXC/8;I&(CHNV6S:7H;JN8E^7,^2'F)[IQ),ZZ4%X2A#"*3 MR@URAS^DK?^-W)NWR61MS$-CQ'!+:56L4C56A[?<4Z.699K_6] UVT>*#@.6 M-QA& D8WW"@(:"Q9*_]QF$MMJN8,W>AP3,4UC#",E(K&+>P>MD?%71H8-.#7 M80NIS(KG(Y?,='0%5"HO'SDK+D%1>?5]LU%JFNN+S)*EWY=U?R(OS,AV8E70 M;8 2&=/PN "J?)G8;/J56!$O2I 9/\(,#V/JX=;>,HD%?>0#E#7E.:MG#&\? M8>>@[0163']_+]RZ<(;7%% JBG'A#C5\4B2Y(+5,%-)>\NJPII%HX6KA@OD@ M5:")QSR8MCX,^!A4VSF[)5?1F(8?BA+V9-":@OMI1_+[/M=SN_7?4&O6Z?G)R?DNX?G;^? MG/_2)9V++U]Z_7[OXOPA_L\EX@66P-Z*J-^I'($TJB@LDM-2IP0FX7I:9E:K? YM4P?EVU6=[I MZEKF'DD>*).K[OF 7'4O+ZX&KZC]MION92)D0L'M5A$!,QH],&)52"2(53WP M/N[]_"-?QP@R#X!#Q[D30$Y<1:#8:E:<-X&&/H0GM/AD>GQA3F M82SX487V22QX0.Q:.H.[JFD51UNS]41P&FQBIKF5FB'O5C/67H(BV]D*TKL& M*:[8-9<8&U*I.Y]"K8(&V_F@1S[U+OJ=7O>\T^T72>^\4]IZ.WQ^&;\+R_4, M.>A.**@HI#L5]9Q>0B61,7/1#_<(#PE7DH!2 TD7FS7R7PK+^Z$>UC'P9?W_ M9K-4:]9V=?\K5JENU^YU_[=_7ZTV=VKQYB95V2I0LBDJDL<]['B"D8]5H5M9 MY"A^!87C/$(#]T(W$F!@Z+A\7X$9T(F24(EI)_+6Q%,*@\!.V3<;2*D5O+<$S'68W2?V?IPRP=T$DO M"W2[&MS+_*V!>UTS;*=2;YKW,_CQNB%@_JKZUPQ\24MENXC%@99]] DC\+4$ M^0^X6M+CVEG,RE?).+C$J3I%+] M?7TWK&_OJD^ZXSB(IDR\O15>5N#D/"JM6^@UAU"O&OW9SC/<=3\[\3S!I,S^ M?(;^K'POJQ?:-NEDVHZ14\%O6)&<<2$5.0NB2+PYM_F1S.G SPLQB&YGAFFC MT.Y'B1J1/A!Q!HZWRZ4;W>5'<8=8_=* >M.\$)=@$'.=:;.EO=PLM#O 9J@= M0R\\MB#X9.]TP7SL-#//S9LJWXHB6(!BT=1 MR$BH=[CB J'@95%-:6N7*# *QPFT7$*'56C7JBO8^+@#!#]'L U>XDR7#6S+ M!JU4:1JV6?EV[#UP1KXOD#T#Z0?;.8WV":T,X)&F0(85]$EZ;.$1B>J"!%3F M\?WOT?/7.U=\=JE?3T%GQ-RO^F2+QK!%@)+#W7L838J%'L!(18"D<1(H&K(HD<&42#"5I#_5+;,&T1 6*[6@LI,T,0]# M)] /0#2.ZV-B=!,/*/0F&._K?RYF&[PK@_2C@+JQ#>/T%]@54H]NBVWD7Z)[S MAXPS!JU"VW(H6*(+Z%[*')EAVP$]JFM^A_=+P?M2,-3=F JO4]_0H!$7OH\> MQ'8PK[X+F .?#'>!40]J<\OQ#/M@^'$[T*=UO\/^E6#?DS)AXA'@KWT'_UKP M5YCA'+C;@3^KNP;\VT:37\ES7##14E>."7 &XW5IGEH39*X=,D]NK/)A' MN%E.I52K.4^6QVQ(&$^4ZWZ0QXL^+*]BZ];<>*2' =/9)/_2^9!)5_+FW90ZT( M9X9CO=!& Q38VE>1^[5(8BK(#0T21G[2WZ%:),;/BD?/FLOW_A8DT[.IUIJM M!IY/GP]Z^\?H_& MO::O=5^%S3I%AV_>;J';TIX?$W8WL'C7+)&\GU]T-YVTERW##;:9A1MJF\,- M^\F]GG\/3#&I8BWF^T6 MR%P]5C#%P?5M1[AT(= &)8+=< GM0$XP,0GT!W5=S+['RGAWCT>%)]-S6&^3 M@U\YH#,'?U$ 2KL#9#*8$9!^*K@M.JS=T;%\!4<L7,HQW\^T M@6K.F] A;&J)6FWR_1Z/;[_'8]R..MO9=F4"+1[4L*3&1\V:AC%QJ1:,FURRL"65HG0;M'9+Z/:$Q' M@4+\SMS)2<2V 4&+228N,$H"GJG\M@E 9UX23!?H7%S&(HK,?-CT>W@!!B55 MHR)!QEV'^@ 'Q2L-PH _AYK1$!CX!'HDUG.$_:2#OVM,R]M]2'I U+S9L7O M(M30L')H^/>+8Y'\\R8*0T8^\SNHAH=>!N142,YF*[$H)+<\@$60$HP)W:N7 M:#L_A^_ZEHMP7@!RB0QF:H(&,EJ8S1=9PBG>%;4%\=_=/E:JIHV"C*!'HP+I4CC1;9R/.C'(@>['_U,8'+V+"Q\D8 MF !47:.#$=-IOJO_5*F;19#4_50F0^I^!3<)>&]D>L77_PY?2LL,=!8JL"W" M)?&8= 6/%]-7-^ &3%R8!#IGX"AIJ8"U&:8KC# .7VSX_U$%#.X M+V**36(03XE=^?C-&TU#+Y,1'W)-)([^6)6 H_]? DJZ8F8J8:^NOUMT"9[) M2[S?K]CYTDGS-5V@?8K,ZD.ZWB_G)X/?KNZY(W Q3F2_6IQH\8ZL-/3S9Y)9 MEC-E\$"HL;@N9J3-7)AM+;)*J3: M!]JD5G.B1I$ XKQ-LOJM7XW%(9]S#T^C\VG6#U4>3B9'R]\&YOKG#JG2\GD[-W&-]]O%ZA2T&[!KA&%Q*( MAA)MF=X@O0'T0\A[]D#0MYKH2L@&XZ6E78CV4;+U1J,HB!('F,XGA."4ZR,L1I!BFFD%9A M,(,D20L;=*=R13?0$-2WQE6^4PMOHW6;^_YVNYUNXZF0:S\*@M"_^[SZ;J'> M@*T9OQ^A=X6L'3[VC;L@"AQ<<]!B/K"/#$K8E<@_Y"&E MH?"&I,L)0D8+UK1" M:L1?I0YBA%F6^3O3G8?VVJT$)=I>B:-B6#PV1QQ&. ZG.U5Z_IO2C@,QKC3A M%$[)W3]AQ_L7-1PF>UH-CG=Z#3:8 CI=BP>_!&8F%[^>7AV#FP,VAW%.PKG0 MEF\L@ZUM&:_$WM";3.&YJ_X:*KCUBY\"Y$__[WD+'=7G\Z_FJQV?9@%\W%*Z%B MG-D;%]A?B/#A4X&199WYS['/HG0*RJ]\:<_/ISJ0!\@?B)34M*M/YQW*.DH; MC$Z\8;G\\7;MGY]LH#7LUWHY^0U02P,$% @ %8.B6*&[N I8"@ E@ M !4 !S;G1I+3(P,C0P-#(V7VQA8BYX;6S-G%UOVS@6AN_[*[C9FUU@6$LB M]<&BS:";:1?%9MJ@23HP,?B9";2F0E2;Y]TO)=B)%DDU2MKHWB>/0YSTO MP\?D(1F__?5AN0 _9+%*\^S=B?_:.P$RX[E(L^MW)]^N/L+DY-?35Z_>_@7" M/__Q]1S\EO.[IMJI_?'=R4Y:W M;V:S^_O[UP^L6+S.B^M9X'EHMFU]LFG^T&E_C^K6/B%D5O_VJ>DJ[6NHP_JS M/W\_O^0W4R87. MOHY6/M[*=R>K='F[D-OG;@JI^L,NBJ(5MGG@Z5[I=\AY/$3;LB,3GD]H#YD8JJQ^R0U.O7C9WRH89&7 M=#'!L'B6::2\J)XXUX\V,E6@'6^FM<[FK;N1JGPH92;D^MVR%1JDXMV)?C07 M,IU?2GY7I.7CAP=^0[-K^9DNY9P&*!!($<@832 .@@0F/@HA]A -A438#\-Y M^32FYS*#WRZW\K7&;H$3"V?E *&%7.5W!5_/;5JTFM?7>9QN)<%6$U2B;V?/ MZ3GTR>+H3A?'-)GS5N!%-4GGQ4LG.=_KY'G0K[25VL9*\M?7^8^9?JFV$Z#J M :P>U&-],."L\U=X7VRSI 7?TV6;%C.>Z_7';0E;O:>*?&EFI\S-_H#K;M.B M)R OA"STFK+'0.\P\@-VE98+.9>$Q212"M(X%A!CO2RD/E'0"T@@8H0%BGQ; MK+;!CXQ4K0%R!?S@;^SO8*MNS]139YCSY&+1CB5;=TXPO;0Q"J2G8)-#]-)& M'T"=-O;P_*'CZ GL+%\N[[)T75&LYBB*/(]Q71W%".F)*8P@E=47FE#&>2+" MA)D2U*MP9(PVFJ M:DY1?Z_L1VFT5SN>+&U:X;33BA-3_1$G VNGH29=NQO: M(U85ZHN+FSR3G^^63!9SQL(X(13!6"$*<8P1)$3ZD$4R$-H51Z$Q72^#'QFL M6@[4>F M: Y5IQ_V\S3&G1U*%L:L,!IRX$10)]AD\ S9:'(SV,8>F:N"5CN( MEX]+EB_F2@4<$2^&6.@*";-0K^>XSR!5(0L\(C%&TI275N1C+^;66F M9@Y* MV_U^2IP]6:[>S.Q8X=&;NA,;[4B3@=%KH$E%?P-[)#YDI5[Q?YD'/.,$^"&$/I>;Z>6'P**?8HC)*("!JP$"-L"HJ!WI'Q M66< 6BG\ NHD=*^!32*@RL2<+9-NW$_<@3O'CL-#](L5I!9NG= UB3\9T!9F MFYC;O,P5_O="Z&&QJN-^*2Z*_$>J['CF!3!!=NW$6*.)) MYIL7:[N$IL%]H]T8T%M]6\@'NLN4[O&=X(2U@W\'F'>;&T'Q0.")\=UMK\OM MGO;VP%X4LJH?I8Y2G79_6JWN9'%5'1047Y32M8\G4:0\3\#0URM9' <13"+I MP0!S*D(9:6XC4VCWB1T97"T/>4,?K!, ZPQ G8(YNWM[;C^_A^P/.X9'=845 MQJ8>G5#>&WPRG$UM-I$V?HT]UMO;*T\'MK_I-XPY0B@*/.[#D'L*8@\S2$A< M'3]$7I10%(78N#[M53@RP$]W%H;M4)RIQDG M#OLC3@;?3D--XG8WM,?L+/\AB_=L51:4EP;#J-7^>,.GE@'_V0K]]S##IC=Y MI^'2CC39,.DUT!P>_0U$5A!D3.BPS=:USD")G5'GS/3#'QD<,[J36:M97EPUO)N4)(Y.K*L MR,S,V-5C/9F[E6/-0--58SWIMXJQOM^//)&ZR%/[4W]I]F_I*OW2NPE"#*%1U%81![',,J6(A] F1 M*/(DEZ%QW=4,/-6F=*5EOQ-=6S??@+8UY+COO-.+TV9S,_%1>\QUH,FWEIOI M]^THMWYO#\)['4-4<3XNZ/7<9XG/J4!0>C'5$Y-4D'EQ JGDNN1)1.#YQBNV M5N0CH_"D!2HQ*$!A'&.M)(N*0)AC!P&=QI%=PBG!AMV9[H3#- MK@J:K=+J.N#Z<'0>QV%(!6$0^:'0DQ"F,$&<0RD"AB-.$$74\J"J(S+1*=4# M>!;>'*E;'U%U.\@4N7&VG:BS0%7;I?,GS4FWM&K]X[S E32CMMYC?ZQW,MS=?3U!6_*_KP2>BE:*HV_WZ\>=OV@@ E7NS! M$%<732,B($61A!%%/$A"/:F97QK?J30-BEH@UU@][U@Y*RY^7:>9M*?JXA315D$HUASBP.L(!%2KS@] MGTO,D* J=IHWFRH3SYR;!Z#2!E\RU\.P5C]9SI^N[L?-H,;&W6?1/F/CY]%6 MU)\SD_89&YQ+>QN[8OE57J?5W>.LK#]@#'/.5%WY<8&JCQ0((?&D!PEE,>*1 M0#ZVG$3; M/ ^*QI^:%KO7UB2I^[4R?P3$TZX-;O9 1I+P).#%F_G2Y? ^V& MT&KVN(;Q^^FK[3/I^B-C3U_]#U!+ P04 " 5@Z)8,'MW%N$& #U,@ M%0 '-N=&DM,C R-# T,C9?<')E+GAM;-5;VV[<1A)]]U?,:E^W-7UC7P1; M@5:Q%T*46+ 5)-@7HB_5,T0XI,"A+.GOMTAI8H\E;QB1@&@)F NGFZ?ZU&%U M57'F]0^WFW+Q"9IM45=O#M@A/5A %>I85*LW![]>OB/FX(?C5Z]>_X.0W__] MX7SQ8QVN-U"UB],&7 MQ<5.TZT6[AL5O=?-'\&>"$TH58K9[7,8I;]:W5D0"9FLD"$ M#HY(&QDQ%@P)8!*C&4AI?'_2LJC^..H>O-O" I=7;?NW;P[6;7MUM%S>W-P< MWOJF/*R;U9)3*I:[T0H _WD_U M0RCKL#>H[%BM_YQ9.@]E?S2/4.3]64_\MFU<:',*4F?22*(TRXB$$(E7($G, MHLRDP#_C]I? 1WS\OS[-Y==9*9U9[1W0T@4B62>*4Q"LALLA]8IK*<69_B;9O]9?^/&G"HFXB-!@V=G"N M"8]\NR_8AQ'+*]?@B4A8%V7,MKFB&H.@R$@(QA"I(T9-+1+)HF#&*RVL MEY.X?@]VD ;X_#7P?"Y?6 QO,3JV=Q]@571,5.TO;@.YDG M=81<,B$\127K(!F1T77+$8P($97U&3?1ZPF$\7^-&*03.7>=3,?S+&3SKBCA ME^N-AR:/WD(&@1.K/-H>E"#>4\"46E 6G4U!3A$\/B,.$D0V=T$\D\%9>/_2 MW9[%+L].Q7WA\;"0X'V@7GKB):Y!>B3#>*.)-)@2!1XII=D$4O@&_"!=J+GK M8@IN9R&2DQC1!=N')RS9@.7 C 2LPDEPBF*B9('@5(U5N@Y!19U4F$(@3T / M$H>>NSC&['FH[07)@#("=3A:? M@0>)PGPGHG@FGW.21)\7O6\NFOI3406LJR H8U(@+&8>>4D18UXF"/>4.2ML M8,"FT\57Z(/$8;\3<8QA=DX*N:BWK2O_6USU:3,U#E-CK+N-XJEKY"9B3*:) MX]8IEKQ14^IC#WM8,XM^)_)X/JTO+(XNZ)TTX'J[7>(!)V&%"F'$/-N;#S&'*:#&?3-Y.+_NUM6+MJ!?VM_.BD!DQT2%118=#2AN#6 MYK!"MB 4=12WNDDN_"]1AVE@QEW'T53.HMOX=@/-"J7\GZ:^:=>XN5VYZBX/ ME$8F;"(N"%R&L8JXCA.+6UAB*I,8Z"9H-SX)/NR+4[/O-XXG=A[ZN,585VV+ MCO_[KX+EQF/)+!5F-J++<60"8E*B),K@G1*6Z<2G$,499KZW/\%=;GDF?% &-SZ'"U!9P I)X:N4L218\L[1"33Q%>PP0S!=6PPF60;$KA=Z5;I6C=8I%Z@CO?FF :5$B/O!$!' :O794^W']Z3VX M8=Z?<4_R^>1-YO77RT?DG>.!XU&UL4$L%!@ $ 0 ! $ %4D $! end XML 17 snti-20240426_htm.xml IDEA: XBRL DOCUMENT 0001854270 2024-04-26 2024-04-26 0001854270 false NASDAQ 8-K 2024-04-26 SENTI BIOSCIENCES, INC. DE 001-40440 86-2437900 2 Corporate Drive, First Floor South San Francisco CA 94080 650 239-2030 false false false false Common Stock, par value $0.0001 per share SNTI NASDAQ true true